• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA Reveals More Details on 22 CAR-T Secondary Cancer Cases

cafead

Administrator
Staff member
  • cafead   Jan 25, 2024 at 11:32: AM
via The FDA is currently looking into at least 22 cases of secondary malignancies in patients after receiving CAR-T therapies, according to a perspective piece from two agency officials published Wednesday in The New England Journal of Medicine.

article source
 

<